Michael E. Prevoznik
At a glance: Michael E. Prevoznik is General Counsel at Quest Diagnostics (DGX). Their latest SEC Form 4, filed Aug 31, 2026, reported a sale of $3.9M. On file: 0 purchase lines ($0) and 6 sale lines ($6.6M).
Disclosed holdings: about $9.7M of DGX stock: 37,557 shares reported on their latest Form 4 (filed Aug 31, 2026), valued at the Nov 19, 2026 close of $259.06. This counts only DGX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
General Counsel at Quest Diagnostics Inc (DGX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Michael E. Prevoznik's InsiderPrint
6 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 6 times a year, typically $800K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.
- Bump outward: a purchase (0)
- Dent inward: a sale (6)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Santos Cardoso Joao Kleber DosCFO · AUGO · 100% match
- Robert O'HareCFO · AFRM · 100% match
- Daniel S. ShugarCEO · NXT · 99% match
- Bradley ViziPresident, Chair · RCMT · 99% match
- Paul V. WoolwayMd, Chief Banking Officer · SCHW · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 31SEC | DGXQuest Diagnostics Inc | Sell Plan | 16,01044,224 held (−27%) | $242.88 | $3.9M | +6.7% |
| Aug 31SEC | DGXQuest Diagnostics Inc | Sell Plan | 6,23737,987 held (−14%) | $243.63 | $1.5M | +6.3% |
| Aug 31SEC | DGXQuest Diagnostics Inc | Sell Plan | 43037,557 held (−1%) | $244.51 | $105K | +5.9% |
| Mar 6SEC | DGXQuest Diagnostics Inc | Sell Plan | 3,87837,557 held (−9%) | $206.21 | $800K | +25.6% |
| Mar 4SEC | DGXQuest Diagnostics Inc | Sell Plan | 52637,557 held (−1%) | $207.73 | $109K | +24.7% |
| Feb 20SEC | DGXQuest Diagnostics Inc | Sell Plan | 1,11138,371 held (−3%) | $204.83 | $228K | +26.5% |
- Sell
General Counsel Michael E Prevoznik sold $3.9M of DGX at $242.88 — cuts the stake by 27%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Michael E Prevoznik sold $1.5M of DGX at $243.63 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Michael E Prevoznik sold $105K of DGX at $244.51 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Michael E Prevoznik sold $800K of DGX at $206.21 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Michael E Prevoznik sold $109K of DGX at $207.73 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Michael E Prevoznik sold $228K of DGX at $204.83 — pre-scheduled 10b5-1 plan sale.
Follow Michael E. Prevoznik
Get one email when Michael E. Prevoznik files a new purchase or sale. Free.
At most one email a day about Michael E. Prevoznik, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.